KEMPHARM, INC (115) | Human Resources (15)
Browse by Subcategory
Recent Contracts
-
Agreement Regarding Employment Terms, dated as of May 13, 2023, between Zevra Therapeutics, Inc. and Christal M.M. Mickle
(Filed With SEC on May 15, 2023)
-
Transition Agreement, dated as of May 6, 2023, between Zevra Therapeutics, Inc. and Richard W. Pascoe
(Filed With SEC on May 8, 2023)
-
EighthAmended and Restated Non-Employee Director Compensation Policyeffective February 15, 2023
(Filed With SEC on March 7, 2023)
-
2023 Employment Inducement Award Plan and forms of award agreements thereunder
(Filed With SEC on March 7, 2023)
-
Amendment to Employment Agreement, dated as of January 6, 2023, between KemPharm, Inc. and Richard W. Pascoe
(Filed With SEC on January 9, 2023)
-
Transition Agreement, dated as of January 4, 2023, as amended, between KemPharm, Inc. and Travis C. Mickle, Ph.D
(Filed With SEC on January 9, 2023)
-
Consulting Agreement, dated as of January 6, 2023, between KemPharm, Inc. and Travis C. Mickle, Ph.D
(Filed With SEC on January 9, 2023)
-
Seventh Amended and Restated Non-Employee Director Compensation Policy
(Filed With SEC on May 12, 2022)
-
Executive Employment Agreement by and between the Registrant and Richard W. Pascoe, dated as of November 5, 2021
(Filed With SEC on November 10, 2021)
-
Amended and Restated 2014 Equity Incentive Plan
(Filed With SEC on August 13, 2021)
-
Sixth Amended and Restated Non-Employee Director Compensation Policy
(Filed With SEC on March 12, 2021)
-
Fifth Amended and Restated Non-Employee Director Compensation Policy
(Filed With SEC on June 24, 2020)
-
Fourth Amended and Restated Non-Employee Director Compensation Policy
(Filed With SEC on November 14, 2019)
-
Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under 2014 Equity Incentive Plan
(Filed With SEC on May 14, 2019)
-
Amended Non-Employee Director Compensation Policy
(Filed With SEC on March 1, 2019)